We are a team that consists of medical doctors, PhD students, research nurses, research assistants and professors.
We currently run weight loss studies such as the REDEFINE study which looks into how well CagriSema works to encourage weight loss in people living with excess body weight.
Emanate Trial (obesity and hunger clinical trial)
A clinical research study including approximately 560 people with rare forms of obesity caused by genetic variants which looks at whether an investigational medication is safe and can improve the body’s ability to control weight and hunger in people with certain genetic variants.
The study focusses on five sub studies of Setmelanotide in obese patients with 6 specific gene defects in the Melanocortin-4 Receptor pathway. The trial provides evidence that feeling full after eating can be controlled by certain genes. You may be able to take part if you are 18-65 years of age and have been identified as having genetic variants that may lead to obesity.
More details to follow.